Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Andera Partners's stake in Mineralys Therapeutics, Inc. fell to 4.20% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Andera Partners's stake in Mineralys Therapeutics, Inc. fell to 4.20%, 2,765,976 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 2,765,976
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Andera Partners | 4.20% | 2,765,976 |
| BioDiscovery 6 FPCI | 4.20% | 2,765,976 |
| Stephane Bergez | 4.20% | 2,765,976 |
| Francois Xavier Mauron | 4.20% | 2,765,976 |